| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.77B | — | +23.0% |
| Cost of Revenue | $940.3M | — | +18.2% |
| Gross Profit | $1.83B | — | +25.6% |
| R&D Expense | $361.9M | — | +14.5% |
| SG&A Expense | $613.3M | — | +8.9% |
| Operating Income | $855.3M | — | +48.0% |
| Pre-tax Income | $940.4M | — | +40.7% |
| Income Tax | $114.4M | — | +425.0% |
| Net Income | $821.5M | — | +17.6% |
| EPS (Basic) | $2.31 | — | +18.5% |
| EPS (Diluted) | $2.28 | — | +18.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.01B | -40.4% | -22.0% |
| Short-term Investments | $2.51B | -2.2% | +29.6% |
| Accounts Receivable | $1.60B | +4.5% | +30.6% |
| Inventory | $1.95B | +5.7% | +25.2% |
| Current Assets | $8.81B | -9.9% | +15.0% |
| Total Assets | $20.11B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $911.9M | — | +56.8% |
| Investing Cash Flow | -$914.5M | — | -528.3% |
| Financing Cash Flow | -$1.35B | — | -474.1% |
| +4.6% |
| Current Liabilities | $1.91B | -4.7% | +24.2% |
| Total Liabilities | $2.51B | -0.1% | +24.9% |
| Stockholders' Equity | $17.47B | -2.0% | +2.2% |